Boehringer Ingelheim USA Corporation
Pharmaceutical company
Based in CT
🤖
AI Overview
With $970K in lobbying spend across 21 quarterly filings, Boehringer Ingelheim USA Corporation is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2021 to 2025.
$970K
Total Spend
5
Years Active
1
Firms Hired
4
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $170K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $200K |
| 2025 | $200K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Agriculture, Budget/Appropriations, Defense
- •Issues related to general agriculture issues, animal health, regulatory processes, COVID-19, appropriations
- •Issues related to general agriculture issues; animal health; regulatory processes; COVID-19
- •Issues related to FY 2022 appropriations
- •National Defense Authorization Act; Issues related to animal health
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Lobbying vs. Federal Contracts
How lobbying spending correlates with contract awards.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.